FDA issues draft guidance for implementing decentralized clinical trials
The U.S. Food and Drug Administration (FDA) on Tuesday said that it is taking additional steps to support the use of decentralized clinical trials (DCTs) for drugs, biologics, and devices, where some or all the trial-related activities occur at locations other than traditional clinical trial sites. Read More
Specialized printer may help vaccines reach more people
Researchers have developed a specialized printer to generate vaccine-filled microneedle skin patches that can be stored long-term without refrigeration. Their research, published Monday in Nature Biotechnology, may eventually bring more vaccines to more people. Read More
Identification of cytokine that drives organ rejection points to better transplant drugs
Researchers have determined the mechanism that drives chronic organ transplant failure and have identified a potential way to stop the rejection process. Read More
Emergency brake keeps bladder cells from turning cancerous
Fred Hutchinson Cancer Center scientists discovered an emergency brake that bladder cells use to ward off tumors even when cancer-promoting genes are turned on. In a study published April 20 in Cancer Cell, the scientists halted human bladder tumor growth in mice, suggesting the brake could be a target for future bladder cancer therapies. Read More
Nanoparticle prodrugs focus anti-cancer immune response to improve risk-benefit profile
Immunostimulatory nanoparticle prodrugs can focus immune attacks against solid tumors to improve the safety and efficacy of cancer treatments, according to a study in mice. Read More
FDA approves cell therapy treatment for transplantation in blood cancer patients
The U.S. Food and Drug Administration (FDA) on Monday approved the product Omisirge, a cell therapy treatment, for transplantation in blood cancer patients. The phase III trial results, published October 21, 2021, in the journal Blood, found the efficacy of Omisirge transplantation superior to standard umbilical cord blood transplantation. Read More
Boston University professor says Texas decision to end mifepristone access contradicts medical opinion
Texas federal district court judge Matthew Kacsmaryk recently ruled to halt the nationwide availability of mifepristone, reversing the U.S. Food and Drug Administration’s (FDA’s) long-standing approval of the drug, widely used to end non-viable and unwanted pregnancies. Read More
Researchers find new target for drug-resistant ovarian cancer
Researchers working in a preclinical study have verified a new target for recurrent drug-resistant ovarian cancer and provided data to support a treatment approach now in clinical trials. The findings were presented on Sunday, during the American Association for Cancer Research (AACR) 2023 annual meeting. Read More
Chemists construct largest ligand-enclosed nanocage to expand drug delivery options
The creation of what its developers believe to be the largest ever ligand-enclosed nanocage has increased the carrying capacity and expanded the utility of drug delivery vehicles. Read More
Shape-shifting antibiotic in study fights resistant infections
Researchers at Cold Spring Harbor Laboratory have created a new weapon against drug-resistant bacteria: an antibiotic that can shape-shift by rearranging its atoms. Read More
Conferences
Science Briefs
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
